Loss of phosphatase and tensin homologue ( PTEN ) function evaluated by loss of PTEN protein expression on immunohistochemistry ( IHC ) has been reported as both prognostic in metastatic colorectal cancer and predictive of response to anti-EGFR monoclonal antibodies although results remain uncertain .